Brief: Mithra Pharmaceuticals Completes Pediatric Study Of Estelle In Adolescent Patients

Mithra Pharmaceuticals SA

20/12/2023 16:49

Dec 20 (Reuters) - Mithra Pharmaceuticals SA  MITRA.BR :
    * COMPLETES PEDIATRIC STUDY OF ESTELLE® IN ADOLESCENT
PATIENTS
    * IMPORTANT MILESTONE FOR MITHRA'S COMMITMENT TO BRING
BENEFITS OF
ESTELLE TO MORE WOMEN
    * POTENTIAL EMA APPROVAL IN PEDIATRIC POPULATION COULD LEAD
TO
SIX-MONTH EXTENSION OF SUPPLEMENTARY PROTECTION CERTIFICATE
(SPC)1 AND HENCE EXTENDED PATENT EXCLUSIVITY
    * LAST SUBJECT, LAST VISIT NOW COMPLETED, WITH DATA EXPECTED
IN Q2
2024

Source text for Eikon:  ID:nGNX3SLQYS 
Further company coverage:  MITRA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))